Meeting
2023 ASCO Gastrointestinal Cancers Symposium
The role of primary tumor resection in synchronous stage IV colorectal cancer: Subgroup analysis.
Authors
Hojung An
St. Vincent's Hospital, The Catholic University of Korea, Suwon, South Korea;
Hojung An , Ji Eun Shin , Byoung Yong Shim , Hyunho Kim , Hyung Soon Park , Hyeon-Min Cho , Bong-Hyeon Kye , Ri Na Yoo , Sung Hwan Kim , Jong Hoon Lee , Kang-Moon Lee , Ji Min Lee , Ji-Han Jung
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session C: Cancers of the Colon, Rectum, and Anus
Track
Colorectal Cancer,Anal Cancer
Sub Track
Patient-Reported Outcomes and Real-World Evidence
Citation
J Clin Oncol 41, 2023 (suppl 4; abstr 47)
DOI
10.1200/JCO.2023.41.4_suppl.47
Abstract #
47
Poster Bd #
C2
Abstract Disclosures
Similar Posters
Poster
2021 Gastrointestinal Cancers Symposium
Inoperable stage IV colorectal cancer with intact primary tumor in patients receiving palliative chemotherapy: Does the response to chemotherapy correlate between primary and metastatic sites? An Irish cancer center experience.
First Author: Ruba Hamed
Poster
2017 ASCO Annual Meeting
Conditional survival analysis of stage IV colorectal cancer patients living >24 months.
First Author: Nadia Dawn Ali
Poster
2017 ASCO Annual Meeting
Baseline cell-free DNA (cfDNA) and metabolic tumor volume (MTV) independently predict outcome in metastatic chemorefractory colorectal cancer (mCRC).
First Author: Erwin Woff
Poster
2015 ASCO Annual Meeting
Utility of surveillance following curative intent resection of metastases.
First Author: Richard M. Lee-Ying